3. Participants (intrahepatic cholangiocarcinoma (CCA), extrahepatic CCA, or gallbladder adenocarcinoma participants) must be determined to have hyaluronan (HA-) high tumor biopsies based on a co-developed investigational assay. Tumor tissue, from the primary lesion or a metastatic lesion are required.